Merck KGaA

Merck KGaA to build new life science hub in Massachusetts

Pfizer, German Merck start first-ever PhIII PD-L1 combo trial for ovarian cancer

Merck KGaA teams with Orange to redesign its computer network

Merck KGaA doubles digital seed funding, adds link to Silicon Valley

Merck KGaA doubles size of VC fund, bringing cap up to $340M

Merck KGaA, Pfizer’s PD-L1 hope shows potential in rare skin cancer

Pfizer to trial triple-threat cancer cocktail therapy

Merck KGaA blueprints fresh growth in Massachusetts R&D ops

Merck KGaA strikes 5-year IT services deal with Unisys